Head of government Aziz Akhannouch chaired today the inaugural meeting of the Board of Directors of the Moroccan Agency for Medicines and Health Products in Rabat.
The agency was established as part of Morocco’s broader health system reform, under the High Patronage of King Mohammed VI and in accordance with the Health System Framework Law 06.22.
During the meeting, the board reviewed key strategic aspects of the agency, including the approval of its action plan, 2025 budget, organizational structure, and staff regulations. Akhannouch emphasized the critical role of the pharmaceutical sector in ensuring national sovereignty over medications, in line with Royal directives. He stressed that the issue of medication transcends healthcare, having a tangible social and economic impact by ensuring equitable access to all segments of society.
The agency’s mandate includes ensuring the availability, accessibility, quality, safety, and efficacy of medicines, as well as monitoring prices, promoting the use of generic drugs and biosimilars, and managing health risks in coordination with relevant sectors.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.